These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23061592)

  • 41. MRI research proposals involving child subjects: concerns hindering research ethics boards from approving them and a checklist to help evaluate them.
    Shiloff JD; Magwood B; Malisza KL
    Camb Q Healthc Ethics; 2011 Jan; 20(1):115-29. PubMed ID: 21223616
    [No Abstract]   [Full Text] [Related]  

  • 42. Exception from informed consent for pediatric resuscitation research: community consultation for a trial of brain cooling after in-hospital cardiac arrest.
    Morris MC; Nadkarni VM; Ward FR; Nelson RM
    Pediatrics; 2004 Sep; 114(3):776-81. PubMed ID: 15342853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Justice, fairness, and membership in a class: conceptual confusions and moral puzzles in the regulation of human subjects research.
    Iltis AS
    J Law Med Ethics; 2011; 39(3):488-501. PubMed ID: 21871044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Children as research subjects--have we exceeded one or two principles?].
    Bratlid D
    Tidsskr Nor Laegeforen; 2004 Feb; 124(4):510-2. PubMed ID: 14983202
    [No Abstract]   [Full Text] [Related]  

  • 45. No-fault compensation for human subjects injured in biomedical research: a public policy conflict.
    Glass JC
    Pharos Alpha Omega Alpha Honor Med Soc; 1985; 48(3):2-7. PubMed ID: 4034661
    [No Abstract]   [Full Text] [Related]  

  • 46. Children's and their parents' views on facing research risks for the benefit of others.
    Wendler D; Jenkins T
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):9-14. PubMed ID: 18180406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is It Ethical to Enroll Cognitively Impaired Adults in Research That Is More Than Minimal Risk With No Prospect of Benefit?
    Taylor HA; Kuwana E; Wilfond BS
    Am J Bioeth; 2015; 15(10):64-5. PubMed ID: 26479112
    [No Abstract]   [Full Text] [Related]  

  • 48. What conditions justify risky nontherapeutic or "no benefit" pediatric studies: a sliding scale analysis.
    Kopelman LM
    J Law Med Ethics; 2004; 32(4):749-58. PubMed ID: 15807363
    [No Abstract]   [Full Text] [Related]  

  • 49. The enforcement of morals: nontherapeutic research on children.
    Ramsey P
    Hastings Cent Rep; 1976 Aug; 6(4):21-30. PubMed ID: 133992
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethical concerns associated with childhood depression.
    Nelson EL
    Bioethics Forum; 2002; 18(3-4):55-62. PubMed ID: 12744271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should children decide whether they are enrolled in nonbeneficial research?
    Wendler D; Shah S
    Am J Bioeth; 2003; 3(4):1-7. PubMed ID: 14744301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ethical and legal issues in pediatric drug research.
    Cohen SN
    Pediatr Pharmacol (New York); 1980; 1(1):25-9. PubMed ID: 7346729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How do institutional review boards apply the federal risk and benefit standards for pediatric research?
    Shah S; Whittle A; Wilfond B; Gensler G; Wendler D
    JAMA; 2004 Jan; 291(4):476-82. PubMed ID: 14747505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human experimentation at the brink of life.
    Oliver AA
    GMU Law Rev; 2001; 9(4):1177-203. PubMed ID: 15233133
    [No Abstract]   [Full Text] [Related]  

  • 55. Omitted considerations and populations: a response to "Should children decide whether they are enrolled in nonbeneficial research?" by David Wendler and Seema Shah (AJOB 3:4).
    Solyom AE
    Am J Bioeth; 2004; 4(1):W39-40. PubMed ID: 15035946
    [No Abstract]   [Full Text] [Related]  

  • 56. Biospecimens, Research Consent, and Distinguishing Cell Line Research.
    Spector-Bagdady K; Fernandez Lynch H; Brenner JC; Shuman AG
    JAMA Oncol; 2019 Mar; 5(3):406-410. PubMed ID: 30703213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protecting subjects who cannot give consent: toward a better standard for "minimal" risks.
    Wendler D
    Hastings Cent Rep; 2005; 35(5):37-43. PubMed ID: 16295263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body matters: rethinking the ethical acceptability of non-beneficial clinical research with children.
    De Clercq E; Badarau DO; Ruhe KM; Wangmo T
    Med Health Care Philos; 2015 Aug; 18(3):421-31. PubMed ID: 25433817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Group benefit and protection of pediatric research subjects: Grimes v. Kennedy Krieger and the Lead Abatement Study.
    Kopelman LM
    Account Res; 2002; 9(3-4):177-92. PubMed ID: 12816126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing pesticides in humans: of mice and men divided by ten.
    Krimsky S; Simoncelli T
    JAMA; 2007 Jun; 297(21):2405-7. PubMed ID: 17551133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.